Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global Neuro-interventional Devices Market, by Product Type (Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy Devices, Embolic Protection Devices, Flow Diverters Devices, Intrasaccular Devices, Liquid Embolic Devices, Balloon Devices and Stent Retrievers), by End User (Hospitals and Clinics), by Technique (Neurothrombectomy Procedures, Cerebral Angiography, Stenting Coiling Procedures, and Flow Disruption), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$  2358.1 million in 2020 and is expected to exhibit a CAGR of  4.0 % over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The global neuro-interventional devices market is expected to witness significant growth, as key companies are focusing on strategic mergers and acquisitions to strengthen their position in the market. For instance, in 2019, Siemens Healthineers AG acquired Corindus Vascular Robotics, Inc., the acquisition will aid in the development of advance technologies in neuro-interventional procedures.

Global Neuro-interventional Devices Market – Impact of Coronavirus (Covid-19)

  • The COVID-19 pandemic has drastically affected every market worldwide and it is expected to affect the global neuro-interventional device market in the following ways:
  • Government initiatives to combat the COVID-19 crisis are expected to hamper the market growth during the forecast period. For instance, according to the Indian Society of Neuroradiology (ISNR) report published in September 2020, stated that healthcare professionals and hospitals are facing various challenges, while following various guidelines and precaution during carrying out interventional procedures, the challenges are stated are as follows:
  • Ascertaining COVID-19 status of the patient before carrying out the interventional procedures, which may lead to time delay for carrying out urgent surgical procedures
  • Delayed response by the emergency room teams, as most of their focus has shifted to other priorities in the COVID-19 pandemic
  • Protecting health care workers from acquiring the infection, especially given the fact that the trained workforce capable of delivering this specialized service is scarce

Browse 33 Market Data Tables and 32 Figures spread through 175 Pages and in-depth TOC on “Global Neuro-interventional Devices Market, by Product Type (Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy Devices, Embolic Protection Devices, Flow Diverters Devices, Intrasaccular Devices, Liquid Embolic Devices, Balloon Devices and Stent Retrievers), by End User (Hospitals and Clinics), by Technique (Neurothrombectomy Procedures, Cerebral Angiography, Stenting Coiling Procedures, and Flow Disruption), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the global neuro-interventional devices market, click the link below:

https://www.coherentmarketinsights.com/market-insight/neurointerventional-devices-market-3200

The global neuro-interventional devices market is expected to witness significant growth during the forecast period, owing to key companies focusing on technological advancements in the neuro-interventional devices market, in order to strengthen their presence in the market. For instance, in November 2019, Corindus, a subsidiary of Siemens Healthineers Company, announced that its CorPath GRX System, an interventional device was used to complete the first robotic assisted neurovascular intervention.

Key Takeaways of the Global Neuro-interventional Devices Market:

  • The global neuro-interventional devices market is expected to exhibit a CAGR of 4.0 % over the forecast period, as key companies are focusing on strategies such as mergers and acquisitions
  • Among product type, neurovascular thrombectomy segment is estimated to hold major market share in 2020, owing to rising prevalence of acute ischemic stroke in individuals globally. According to Center of Disease Control and Prevention report published in 2018, stated that approximately 1 individual out of 6, were died due to stroke globally in year 2018
  • Among technique, the neurothrombectomy procedure is estimated to account for major market share in 2020, owing to less minimally invasive procedure and also less pain experienced by patients after neuro-interventional surgery
  • Key players operating in the global neuro-interventional devices market include Stryker Corporation, Penumbra Inc., Medtronic, Johnson & Johnson Private Limited, Imperative Care, Inc., Anaconda Biomed SL, Insera Therapeutics, Perflow Medical Ltd., Terumo Corporation, MicroPort, and Rapid Medical Ltd.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.